Tiotropium HandiHaler^® in the treatment of COPD: A safety review

References

• CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol200616637016039877
   PubMed Web of Science ®Google Scholar
• AnthonisenNRSkeansMAWiseRAManfredaJKannerREConnettJELung Health Study Research GroupThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med200514223323915710956
   PubMed Web of Science ®Google Scholar
• AnthonisenNRPrognosis in chronic obstructive pulmonary disease: results from multicenter clinical trialsAm Rev Respir Dis1989140S95S992675713
   PubMed Web of Science ®Google Scholar
• Domingo-SalvanyALamarcaRFerrerMHealth-related quality of life and mortality in male patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200216668068512204865
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMCoteCCabralHTaylorJCelliBRThe 6-min walk distance: change over time and value as a predictor of survival in severe COPDEur Respir J200423283314738227
   PubMed Web of Science ®Google Scholar
• HoleDJWattGCMDavey-SmithGHartCLGillisCRHawthorneVMImpaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ19963137117158819439
   PubMed Web of Science ®Google Scholar
• RabeKRHurdSAnzuetoAGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive SummaryAm J Respir Crit Care Med200717653255517507545
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyStandards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD)Am J Respir Crit Care Med1995152S77S1207582322
   PubMed Web of Science ®Google Scholar
• KestenSJaraMWentworthCLanesSPooled clinical trial analysis of tiotropium safetyChest20061301695170317166984
   PubMed Web of Science ®Google Scholar
• CelliBDecramerMLeimerIVogelUKestenSTashkinDCardiovascular safety of tiotropium in patients with COPDChest710 [Epub ahead of print]
   Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921722411866001
   PubMed Web of Science ®Google Scholar
• CalverleyPMLeeATowseLWitekTJJrKestenSEffect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax20035885586014514937
   PubMed Web of Science ®Google Scholar
• McNicholasWTCalverleyPMALeeAEdwardsJCon behalf of the Tiotropium Sleep study in COPD investigatorsEffects of long-acting anticholinergic therapy (tiotropium) on oxygen saturation and sleep quality in adults with severe COPDEur Respir J20042382583115218993
   PubMed Web of Science ®Google Scholar
• BrusascoVHodderRMiravitllesMHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax20035839940412728159
   PubMed Web of Science ®Google Scholar
• O’DonnellDFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J20042383284015218994
   PubMed Web of Science ®Google Scholar
• DusserDBravoMLIaconoPThe effect of tiotropium on exacerbations and airflow in patients with COPDEur Respir J20062754755516507855
   PubMed Web of Science ®Google Scholar
• VerkindreCBartFAguilaniuBThe effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary diseaseRespiration20067342042716484769
   PubMed Web of Science ®Google Scholar
• CelliBZuWallackRWangSKestenSImprovement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumesChest20031241743174814605043
   PubMed Web of Science ®Google Scholar
• MaltaisFHamiltonAMarciniukDImprovements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest20051281168117816162703
   PubMed Web of Science ®Google Scholar
• CasaburiRKukafkaDCooperCBWitekTJKestenSImprovement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest200512780981715764761
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSfor the UPLIFT investigatorsA four year trial of tiotropium in patients with chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• AmbrosinoNFoglioKBalzanoGPaggiaroPLLessiPKestenSTiotropium Multicentric Italian Study GroupTiotropium and exercise training in COPD patients: effects on dyspnea and exercise toleranceInt J Chron Obstruct Pulmon Dis20083477178019281092
   PubMedGoogle Scholar
• TonnelABPerezTGrosboisJMVerkindreCBravoMLBrunMTIPHON study groupEffect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPDInt J Chron Obstruct Pulmon Dis2008330131018686739
   PubMedGoogle Scholar
• BeehKMBeierJBuhlRStark-LorenzenPGerkenFMetzdorfNATEM-Studiengruppe. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]Pneumologie20066034134616761228
   PubMedGoogle Scholar
• ChanCKNMaltaisFSigouinSHaddonJMFordGA randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary diseaseCan Respir J20081446547218060091
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilatorAnn Intern Med2005143319326
   Web of Science ®Google Scholar
• PowrieDJWilkinsonTMADonaldsonGCEffect of tiotropium on sputum and serum inflammatory markers and exacerbations in chronic obstructive pulmonary diseaseEur Respir J20073047247817504798
   PubMed Web of Science ®Google Scholar
• FreemanDLeeAPriceDEfficacy and safety of tiotropium in COPD patients in primary care–the SPiRiva Usual CarE (SPRUCE) studyRespir Res200784517605774
   PubMed Web of Science ®Google Scholar
• JohanssonGLindbergARombergKNordstromLGerkenFRoquetABronchodilator efficacy of tiotropium in patients with mild to moderate COPDPrim Care Respir J20081716917518536860
   PubMedGoogle Scholar
• MoitaJBárbaraCCardosoJTiotropium improves FEV1 in patients with COPD irrespective of smoking statusPulm Pharmacol Ther20082114615117693107
   PubMed Web of Science ®Google Scholar
• CovelliHBhattacharyaSCassinoCConoscentiCKestenSAbsence of electrocardiographic findings and improved function with daily tiotropium in patients with chronic obstructive pulmonary diseasePharmacotherapy2005251708171816305289
   PubMed Web of Science ®Google Scholar
• CrinerGJSharafkhanehAPlayerREfficacy of tiotropium inhalation powder in African-American patients with chronic obstructive pulmonary diseaseCOPD20085354118259973
   PubMedGoogle Scholar
• MagnussenHBugnasBvan NoordJSchmidtPGerkenFKestenSSpirometric improvements with tiotropium in COPD patients with concomitant asthmaRespir Med2008102505617920256
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyStandardization of spirometry – 1994 updateAm J Respir Crit Care Med1995152110711367663792
   PubMed Web of Science ®Google Scholar
• GreenlandSRobinsJEstimation of a common effect parameter from sparse follow-up dataBiometrics19854155684005387
   PubMed Web of Science ®Google Scholar
• RothmanKJGreenlandSRothmanKJGreenlandSMeasures of disease frequencyModern Epidemiology2nd edPhiladelphia, PALippincott–Raven Publishers19982946
   Google Scholar
• ReisIMHirjiKFAfifiAAExact and asymptotic tests for homogeneity in several 2 × 2 tablesStat Med19991889390610363329
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEEnrightPLManfredaJLung Health Study Research GroupHospitalizations and mortality in the Lung Health StudyAm J Respir Crit Care Med200216633333912153966
   PubMed Web of Science ®Google Scholar
• LanesSGolishWMiklJIpratropium and Lung Health Study (letter)Am J Rev Respir Crit Care Med20031677801
   Web of Science ®Google Scholar
• WedzichaJACalverleyPMASeemungalTAHaganGAnsariZStockleyRAINSPIRE InvestigatorsThe prevention of COPD exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med2008177192617916806
   PubMed Web of Science ®Google Scholar
• LanesSFJaraMThe INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroidsAm J Resp Crit Care Med200817854354418713851
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKFurbergCDInhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary diseaseJAMA20083001439145018812535
   PubMed Web of Science ®Google Scholar
• SalpeterSRBronchodilators in COPD: impact of B-agonists and anticholinergics on severe exacerbations and mortalityInt J COPD200721118
   Google Scholar
• LeeTAPickardASAuDHBartleBWeissKBRisk of death associated with medications for recently diagnosed chronic obstructive pulmonary diseaseAnn Intern Med200814938039018794557
   PubMed Web of Science ®Google Scholar
• JaraMLanesSFWentworthC3rdMayCKestenSComparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care databaseDrug Saf2007301151116018035867
   PubMed Web of Science ®Google Scholar
• de LuiseCLanesSFJacobsenJPedersenLSorensenHTCardiovascular and respiratory hospitalizations and mortality among users of tiotropium in DenmarkPharmacoepidemiology200722267272
   Google Scholar
• GershonAWangLToTLuoJUpshurRESurvival with tiotropium compared to long-acting beta-2-agonists in chronic obstructive pulmonary diseaseCOPD2008522923418671148
   PubMedGoogle Scholar
• KestenSPlautzMPiquetteCAHabibMPNiewoehnerDEPremature discontinuation of patients: a potential bias in COPD clinical trialsEur Respir J20073089890617690120
   PubMed Web of Science ®Google Scholar